ArticleOpen medicine (Warsaw, Poland)2025
Engineered RBC-derived nanovesicles functionalized with tumor-targeting ligands: A comparative study on breast cancer targeting efficiency and biocompatibility.
Fulan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.